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Absence of FMLP Receptors on Rat Macrophages
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Although rat peritoneal neutrophils in the presence of cytochalasin B demonstrate
superoxide (02) responses to the chemotactic peptide N’-formyl-met-Ieu-phe (FMLP),
neither elicited rat peritoneal macrophages nor rat alveolar macrophages show an #{176}2
response to FMLP (in the presence or absence of cytochalasin B), although a good #{176}2
response to opsonized zymosan is demonstrated by both types of macrophages. Using
Fura-2 loaded cells, peritoneal macrophages failed to show an increase in intracellular
calcium after exposure to FMLP, f-nor-leu-phe, F-met-met-met, or F-norleu-leu-phe-
norleu-lys. FMLP also failed to induce elevations in intracellular calcium in alveolar
macrophages. In 3H-FMLP binding studies, the lack of responsiveness of peritoneal and
alveolar macrophages was associated with the lack of FMLP receptors on these cell types,
in striking contrast to the presence of functional receptors on rat neutrophils.
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INTRODUCTION
The discovery that bacterial culture supernatants are
chemotactic for leukocytes [49] led to the isolation and
characterization of small N-formylated chemotactic pep-
tides. Formyl-met-leu-phe (FMLP) has become the most
widely studied of these peptides [38,39]. FMLP also has
been shown to cause enzyme release [3 ,6, 1 2], upmodu-
lation of leukocyte adhesion molecules [15 ,34,46], prim-
ing [5] , and direct stimulation of the superoxide response
[3,6,9,12,38] in a variety ofcells including neutrophils,
monocytes, macrophages, and eosinophils . FMLP recep-
tors have been characterized on human [5 1 1, rat [29],
rabbit [I] , and horse [42] neutrophils, human monocytes
[7], and guinea pig macrophages [8,43]. The FMLP
receptor is a classical guanine nucleotide binding protein
(g-protein) linked receptor [4] , occupancy of which leads
to phospholipase activation and elevations in intracellular
inositol 1 ,4,5-trisphosphate [Ins(1 ,4,5)P3] [ 10, 1 1], dia-
cylglyerol [23,26], intracellular Ca2 [25], and cyclic
adenosine monophosphate (cAMP) [41].
Recently, we have observed that FMLP was incapable
of eliciting superoxide responses or elevations in cyto-
solic Ca2 in rat alveolar macrophages whereas blood
and peritoneal neutrophils were fully responsive [21].
Because of these observations, rat alveolar macrophages
and elicited rat peritoneal macrophages, both of which
failed to demonstrate O2 responses after stimulation
with FMLP, were examined for evidence of FMLP
receptors. Using the changes in intracellular Ca2 con-
centration ([Ca2]1) as a sensitive indicator of receptor-
ligand interaction, no relevant response to FMLP or other
formyl peptides was demonstrated in rat macrophages.
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Failure to respond can be ascribed to a lack of surface
receptors for FMLP. These data have implications for the




Unless otherwise specified, reagents were purchased
from Sigma Chemical Co. (St. Louis, MO). N’-FMLP,
N’-formyl-norleu-leu-phe (FNLP), N’-formyl-met-met-
met (FMMM), and N’-formyl-norleu-leu-phe-norleu-tyr-
lys (FNLPNTK) were stored at 2 mM in dimethyl
sulfoxide (DMSO) and diluted in Hanks’ balanced salt
solution (HBSS) when needed. Plasma opsonized zymo-
san (POZ) was prepared by incubating boiled zymosan
Abbreviations: FMLP, formyl-met-leu-phe: [3HJFMLP. formyl-met-
leu-l3Hlphe: FNLP, formyl-norleu-leu-phe; FMMM, formyl-met-met-
met; FNLPNTK, formyl-norleu-leu-phe-norleu-tyr-lys; ins(l ,4,5)P3,
inositol 1 .4,5-trisphosphate; HBSS, Hanks’ balanced salt solution;
PAF, platelet activating factor; POZ, plasma opsinized zymosan; PBS,
phosphate buffered saline; Fura-2/AM, acetoxymethyl ester of Fura-2;
[Ca2]1, intracellular Ca2 concentration; K1). dissociation constant;
EGTA, ethylenegIycol-bis(3-amino-ethyl ether)-N,N,N’ ,N’-tetraace-
tate acid; g-protein. guanine nucleotide binding protein; cAMP, cyclic
adenosine monophosphate; DMSO. dimethyl sulfoxide; SOD, super-
oxide dismutase; PMA, phorbol myristate acetate.
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with fresh heparinized rat plasma at 37#{176}Cfor 30 mm,
followed by centrifugation and washing prior to use.
Platelet activating factor (PAF, l-0-alkyl-2-acetyl-SN-
glyceryl-3-phosphorycholine, 2 mg/ml), was stored in
CHC11 and dried under nitrogen prior to use. Formyl-
met-leu-[3H]phe ([3H]FMLP) was purchased from Am-
ersham Corp. (Arlington Heights, IL).
Preparation of Rat Alveolar Macrophages and
Peritoneal Neutrophils
Sprague Dawley retired breeder rats (300-500 g) were
used for all experiments. Peritoneal macrophages were
elicited by the injection of autoclaved 10% (wt/vol)
sodium caseinate in pyrogen-free 0.9% (wtlvol) sodium
chloride solution (Abbott Laboratories, Chicago, IL).
Cells were harvested 3-6 days later by peritoneal lavage
with 50 ml of heparinized ( 1 U/ml) sodium chloride
solution. Macrophages were further purified on percoll
gradients by mixing 3.4 ml cells in phosphate buffered
saline (PBS, 140 mM NaCl, 1 mM KH2PO4, 5 mM
NaPO4, pH 7.3), with 6.8 ml ofmodified percoll solution
(specific gravity 1 .099 containing: 0.61 ml 1 .5 M NaC1,
1 .201 ml H20, and 4.88 ml of percoll [Pharmacia LKB,
Uppsala, Sweden]). The mixture was centrifuged at
2,000g for 20 mm. Cells were harvested from the top of
the gradient and washed twice in PBS prior to use.
Alveolar macrophages were obtained by bronchoalveolar
lavage using 7 ml sterile saline (at 37#{176}C)for each of seven
lavages. This resulted in a cell yield of 6-7 X 106
macrophages per animal . Peritoneal neutrophils were
elicited by the injection of 1% glycogen for 4-16 h and
the cells recovered by peritoneal lavage. Neutrophils
were washed once with PBS and used without further
purification. To obtain rat peripheral blood neutrophils,
heparinized whole blood diluted 1:1 with PBS was
layered onto Ficoll-hypaque (specific gravity 1 .077),
centrifuged (400g, 30 mm), and the red blood cell layer
containing the neutrophils incubated in a lysing solution
of NH4C1. The neutrophils were then washed and resus-
pended in HBSS. Differential counts using crystal violet
staining of the nuclei were performed in each case.
Typical results of the cell content of the various prepa-
rations are shown in Table 1.
Measurement on Intracellular Calcium Changes
Rat macrophages and neutrophils were loaded with the
acetoxymethyl ester of Fura-2 (Fura-2/AM) (acetoxy-
methyl ester) (Calbiochem, La Jolla, CA) by suspending
cells in 5 iM Fura-2/AM for 15 mm at 37#{176}Cthen diluted
1 : 10 and incubated for an additional 15 mm . After
loading, cells were centrifuged and resuspended in HBSS
and stored on ice. Just prior to use, aliquots were
centrifuged (450g. 3 mm) and the cells resuspended in
HBSS.
TABLE 1 . Purity of Cell Preparationsa
Cell co ntent (% of total)
Mononuclear
Preparation phagocytes Neutrophils Others’
Peritoneal macrophages 90 ± 2 3 ± 2 7 ± 2
Alveolar macrophages 97 ± 2 1 ± 1 2 ± 1
Blood neutrophils 1 7 ± 4 74 ± 4 4 ± 2
Peritoneal neutrophils 4 ± 3 95 ± 2 1 ± 2
a Based on differential counts of crystal violet stained nuclei.
b Mainly lymphocytes.
Changes in Ca2  -dependent fluorescence were mea-
sured in a Perkin Elmer LS-50 luminescence spectrom-
eter using a thermally equilibrated cuvette holder at 37#{176}C,
with dual excitation wave lengths of 340 and 380 nm and
the emission wave length of 500 nm. [Ca2]1 were
determined using the equation described by Grynkiewiez
et al. [20] where Fmax represents the maximum fluores-
cence following the lysis of cells with 0.2% Triton
X-lOO, and Fmin represents the fluorescence following
the addition of EGTA (10 mM, pH 10.5).
Measurement of Superoxide Responses
Generation of superoxide anion (02) was determined
by the superoxide dismutase (SOD) inhibitable reduction
of ferricytochrome c as described previously [48]. Pre-
warmed cells were added to a reaction mixture containing
ferricytochrome c (80 M) and agonist with or without
SOD (85 U/ml). The difference in reduction of ferricy-
tochrome c in the presence and absence of SOD, as
determined spectrophotometrically at 550 nm, was mea-
sured and superoxide production calculated as described
previously [48].
[3H]FMLP Binding
Cells were suspended in PBS containing 1 .8 mM
Ca2 0.8 mM Mg2 , and 1 mM phenylmethylsulfonyl
fluoride. For [3H]FMLP binding, 100 pi (106) cells were
incubated with 25 l of [3H]FMLP (0.5-30 nM) and 25
il of either buffer or cold FMLP (final concentration 10
riM). After equilibration for 45 mm at 4#{176}C,cells were
harvested by rapid vacuum filtration over glass fiber
filters (Whatman GF/C, Whatman International, Maid-
stone, United Kingdom) and washed with 16 ml of ice
cold PBS containing calcium and magnesium. Filters
were then put into scintillation vials, dried overnight, and
5 ml ofscintillation fluid was added (Biosafe II, Research
Products International, Mount Pleasant, IL) and assessed
in a Beckman LS 5000TD scintillation counter (Fuller-
ton, CA). Scatchard curves were plotted with the aid of



























As indicated in the text or Figure legends, the number
(n) of separate experiments from which the data were
derived is listed. Data were expressed as mean (x) ± 1
standard error of the mean (SE). Statistical significance
was defined as P < 0.05.
RESULTS
FMLP Responses of Rat Neutrophils and
Macrophages
In order to assess the O2 responses of rat neutrophils
and macrophages to FMLP, glycogen-elicited peritoneal
neutrophils, peripheral blood neutrophils, alveolar mac-
rophages, and casein-elicited peritoneal macrophages were
exposed to HBSS, FMLP ( 1 pM), and POZ (1 mg/ml)
(Fig. 1). Since it has been shown previously that rat
neutrophils require the presence of cytochalasin B for
reliable O2 responses [27,50], blood and peritoneal
neutrophils were stimulated in the presence of 2.5 jiM
cytochalasin B. In the absence of cytochalasin B, the
responses of peripheral blood neutrophils to FMLP were
<2.5 nmol O2/30 min/106 cells, barely above the
negative control (1 . 18 ± 0.41 nmol O2) consistent with
our earlier findings [33].
Both peritoneal and alveolar macrophages were unre-
sponsive to 1 jiM FMLP (Fig. lB). With peritoneal
macrophages there was failure of the cells to respond to
FMLP whether or not cytochalasin B was present, while
the O2 response to POZ was unaffected by the addition
of cytochalasin B (Fig. lB). In the absence of cytocha-
lasin B , alveolar macrophages had higher background
levels of 02 production (3.90 ± 0.07 nmol/30 min/106
cells), and the response to FMLP was similar to the
background value (3.68 ± 0.39 nmol O2) (Fig. lB).
The addition of cytochalasin B to alveolar macrophages
resulted in somewhat lower background and FMLP
values of O2 (2.2 1 ± 0.44 and 1 .62 ± 0.05 nmol,
respectively) (data not shown). In a companion experi-
ment, in the absence or presence of cytochalasin B, the
POz responses were 7.97 ± 0.05 and 8.09 ± 0.69 nmol
02  respectively (data not shown), indicating that
cytochalasin B does not enhance 02 response of alve-
olar macrophages, a finding consistent with our earlier
studies [18,33]. Over a wide dose range of FMLP (100
OnM-5 jiM), production of O2 by peritoneal macro-
phages was not different from unstimulated cells incu-
bated in HBSS (n = 5, data not shown). The presence of
cytochalasin B did not enhance the response to either
agonist, similar to earlier findings [50]. This stands in
contrast to the enhancing effects of cytochalasin B on
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Fig. 1 . O2 responses of glycogen-elicited peritoneal neutro-
phils and peripheral blood neutrophils (A), and casein-elicited
peritoneal macrophages or alveolar macrophages (B) following
the addition of HBSS, FMLP, or POZ. Responses were measured
in the presence (+cyto B) or absence (no cyto B) of 2.5 iM
cytochalasin B. *f3 < oo5, **p < 0.005, N.S., not significant,
each compared to buffer control alone (n = 4 for all conditions
except peritoneal neutrophils with cytochalasin B where n = 6).
Changes in Cytosolic Ca2 Following Exposure
to Formyl Peptides
In neutrophils, exposure to FMLP results in changes in
cytosolic Ca2 that occur (in the absence of cytochalasin
B) at concentrations that are 10 to 100 fold lower than
those necessary for 02 responses [25,37]. Therefore
changes in [Ca2]1 serve as a sensitive indicator for
receptor occupancy in g-protein/phospholipase C linked
receptors . Accordingly , cytosolic Ca2  concentrations
were measured in Fura-2 loaded neutrophils and mac-
rophages. The results are summarized in Table 2 where
maximal changes in [Ca2]1 are indicated after addition
of agonist. The addition of FMLP ( 1 jiM) or PAF (10
jiM) to neutrophils or addition of PAF (10 jiM) to
macrophages resulted in a rapid rise in cytosolic Ca2
that peaked within the first 30 sec (data not shown). Table
. 2± .
2 shows the resting [Ca ] and the peak cytosolic Ca
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TABLE 2. Effects of Formylated Peptides and PAF on Intracellular Ca2 Levels in
Rat Neutrophils an d Macrophages
Agonist Intracellular
Peak 1ev el of intracellular C a2 (nM)b
Peritoneal Peritoneal Alveolar
employeda Ca2+ neutrophils macrophages macrophages








106 ± I I
308 ± 44
(P < 0.005)






































PAF platelet activating factor (see above); FMLP, N’-formyl-met-leu-phe; FNLP, N’-formyl-
norleu-leu-phe; FMMM, N’-formyl-met-met-met; FNLPNTK, N’-formyl-norleu-leu-phe-
norleu-tyr-lys.
bAs measured by intracellular calcium-dependent Fura-2 fluorescence.
C Basal intracellular Ca2 prior to addition of agonist; peak Ca2 reflects highest intracellular Ca2
concentration following addition of agonist.
d ND, not done.
*P values, comparing basal to peak intracellular Ca2 levels. N.S., not significant (P > 0.05).
concentration occurring within 30 sec after addition to
Fura-2 loaded peritoneal neutrophils and macrophages of
I jiM of each of the following formylated peptides:
FMLP, FNLP, FNLPNTK, and FMMM. The first three
have been shown to be potent chemotactic peptide
receptor ligands in neutrophils and macrophages of other
species [2,31 ,53]. PAF (10 jiM) was used as a reference
agonist. The addition to neutrophils of each of the formyl
peptides resulted in elevations in cytosolic Ca2 , ranging
from 323 ± 29 to 273 ± 46 nM, levels that were similar
to the maximal neutrophil response to PAF (304 ± 29
nM). In contrast, in macrophages exposed to formyl
peptides [Ca2 ] rose by 1 % to 10% , but these were not
statistically significant (n = 4).
Similar experiments were performed with alveolar
macrophages. Because ofthe limits in the number of cells
available for these studies, calcium measurements were
limited to the agonists , FMLP (1 jiM) and PAF (10 jiM).
The resting and peak increases in the [Ca2]1 30 sec
following the addition of FMLP are described in Table 2.
When resting [Ca2]1 was compared to that obtained 30
sec after the addition of FMLP to alveolar macrophages,
there was an extremely small but a statistically significant
rise in [Ca2]1 (of 1 1 nM) above resting [Ca2]1 (n = 8).
This was, however, entirely attributable to a small
upward drift in Ca21-dependent fluorescence due to
leakage of Fura-2 from cells (data not shown). In each of
eight experiments the slope of the fluorescence tracing
during the prestimulatory period was equal to the slope
following the addition of FMLP (data not shown). These
data indicate that alveolar macrophages do not mobilize
intracellular Ca2 in response to FMLP, in contrast to
their ability to respond to PAF.
[3HJFMLP Binding to Rat Neutrophils and
Macrophages
Having established that rat peritoneal and alveolar
macrophages lack the functional and biochemical re-
sponses associated with cell activation by FMLP, exper-
iments were performed to determine if receptor specific
binding could be detected on macrophages. Figure 2
shows the [3H]FMLP binding to 106 cells in the presence
and the absence of an excess of cold FMLP, permitting
calculation of nonspecific and total [3H]FMLP binding.
The difference between the total and nonspecific binding
under these conditions is by convention indicative of
specific binding to surface receptors. In Figure 2A,
peritoneal neutrophils showed a concentration-dependent
increase in [3H]FMLP binding. Receptor specific binding
represented 73% of the total binding at the highest










a Binding conditions are as described for the experiments indicated in
Figure 2, with 12 pM [3H]FMLP.
bRefers to number of separate experiments.
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Fig. 2. [3H]FMLP binding to peritoneal neutrophils (A) and
peritoneal macrophages (B) in the presence (total binding) or
absence (nonspecific binding) of 10 M unlabeled FMLP. Each
point represents the x ± 1 standard deviation of triplicate de-
terminations from a single experiment. One femtomole of
[3H]FMLP = 110 dpm. Results are representative of three
separate experiments.
concentration of FMLP (30 nM). Scatchard analysis of
these data showed a KD of 16.8 nM, with 10,991
receptors per cell. Under identical conditions, peritoneal
macrophages showed no difference between total and
nonspecific binding over [3H]FMLP concentrations of
0.5-30 nM (Fig. 2B). Actual binding data as well as
statistical comparisons of [3H]FMLP binding at 12 nM
[3H]FMLP for neutrophils, peritoneal macrophages, and
alveolar macrophages are shown in Table 3. Unlike
neutrophils, peritoneal and alveolar macrophages showed
no difference between total and nonspecific binding and
thus, no evidence ofreceptor binding. Therefore, the lack




Alveolar macrophages 3 82 ± 2 86 ± 5 (N.S.)
Peritoneal macrophages 6 1 7 1 ± 38 1 7 1 ± 23 (N.S.)
Peritoneal neutrophils 6 238 ± 44 849 ± 195*
macrophages can be ascribed to a lack of surface
receptors.
DISCUSSION
Functional responses to FMLP have been described in
neutrophils from a wide variety of species such as rat,
rabbit, horse, guinea pig, and human [3,8,12,27,32,40,
42,50,54]. These responses correlate with the presence of
specific formylated peptide receptors on the cell surface
[1 ,29,42,5l]. In general these receptors are of relatively
high affinity (KD of 1-30 nM) with 10-l0 binding sites
per cell. In contrast, no functional responses were found
in neutrophils from the cat [13, 19], dog [35,45], cow
[5,18], sheep [52], orpig [16,36]. Ligand binding studies
suggest that canine and porcine neutrophils lack FMLP
receptors [16,45]. Whether neutrophils from the cat,
cow, or sheep have similar deficits in receptor expression
remains to be determined. As has been shown in equine
neutrophils, the lack of a single response to FMLP (e.g.,
chemotaxis) does not necessarily correspond to a lack of
surface FMLP receptors [42].
The activity of formylated peptides on monocytes and
macrophages is not as well reported, with FMLP re-
sponses in human and guinea pig alveolar macrophages
being the best described [14,22,30]. Our report has
shown that, while FMLP receptors are present on rat
neutrophils, resident and elicited macrophages in the
same animals lack this receptor. Rat macrophages have
recently been shown to be capable of being primed for
enhanced 02 responses to immune complexes after
contact with PAF, ionomycin, or phorbol myristate
acetate (PMA) [2 1]. Using the same protocols we have
failed to find evidence for increased binding of
[3H]FMLP (data not shown), suggesting that cryptic
receptors for FMLP do not exist in rat alveolar macro-
phages. Our study indicates that FMLP receptor expres-
sion on neutrophils is not predictive of receptor expres-
sion on other cell types within the same species.
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Although FMLP has biological activity in vivo in the dog
and cat, whose neutrophils lack an FMLP response
[24,47], this activity is probably not related to direct
effect of FMLP on the neutrophil and may reflect that
FMLP first activates another cell type, products of which
can then activate neutrophils.
The absence of a chemotactic receptor for bacterial
peptides would be expected to be a biological disadvan-
tage since alveolar macrophages represent the first line of
defense in combating airborne infections. The rat does
not appear to be unique since, in preliminary experi-
ments, mouse macrophages also do not respond to FMLP
with increases in intracellular Ca2 (data not shown).
The lack of response to the formylated peptides tested
may be of no functional significance in vivo. It is possible
that a response to another combination of formylated
peptides or entirely different chemoattractants/stimulants
(e.g. , C5a) compensates for this selective defect
[16, 17,28,44]. Alternatively, insensitivity to the bacte-
rial chemotactic peptides may be an adaption by some
rodent species which are constantly exposed to bacterial
aerosols because of their habitat. This insensitivity may
prevent repeated macrophage activation leading to
chronic lung injury and fibrosis. On the basis of these
observations, in vivo inflammatory responses to FMLP
may reflect the engagement of complex inflammatory
cascades, some resulting in indirect stimulation of in-
flammatory cells, rather than a direct activation by FMLP
of inflammatory cells.
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